Skip to main content
. Author manuscript; available in PMC: 2012 Aug 11.
Published in final edited form as: Vaccine. 2011 Jun 28;29(35):5824–5836. doi: 10.1016/j.vaccine.2011.06.083

Fig. 3.

Fig. 3

Schematic flow chart representing the HSV infection-reactivation cycle and the potential targeted step where therapeutic vaccine should intervene this cycle. The blue arrow indicates infections, latency, spontaneous reactivation, viral shedding, recurrent infection and eye disease. The brown arrow and the brown cross -indicated inhibition of spontaneous reactivation, viral shedding, recurrent infection and eye disease.